You are cordially invited to submit a manuscript to the Journal of Pharmacy & Pharmacognosy Research (JPPRes) (ISSN 0719-4250), an international, bimonthly specialized and peer-reviewed open access journal devoted to the publication of original contributions in relevant areas, which publishes original research articles, reviews, letters and guest edited single topic issues in all areas of Pharmacy and Pharmacognosy in English or Spanish.
Papers of JPPRes are opening accessible at the journal’s homepage: www.jppres.com, and you are invited to read or download them freely for the academic exchanges.
The Audience of JPPRes could be: Biochemists, Biotechnologists, Botanists, Chemical Engineers, Clinical Pharmacologists, Medical Scientists, Medicinal Chemists, Natural Product Chemists,
Pharmaceutical Scientists, Pharmacologists, Pathologists, Plant Scientists, and Toxicologists, among others.
Frequency of publication: Electronic versions of articles are published immediately and continuously once the manuscripts have been accepted. JPPRes has an acceptance rate of 22% (2021). The average time between submission and final decision is 100 days and the average time between acceptance and final publication is 15 days. JPPRes does not charge any fee for authors submitting manuscripts. However, an article-processing charge (APC) of 600 USD (US Dollars) applies to papers accepted after peer review.
You are welcome to submit your manuscript to this journa through the following link: www.jppres.com/submit-article
Please, visit the Author Guidelines, Submit an Article or contact us if you have any questions about the journal.
Prof. Gabino Garrido
Editor in Chief
Issue In Progress:
Last Update: January 20th, 2023
© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health